Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Relapsed or Refractory Large B-cell Lymphoma
Related studies linked through entity extraction aliases.
Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2